Measuring transit time between
pulse waves taken from a patient’s finger
and toe. Test results return in 2 minutes.
This independent risk factor predicts cardiovascular morbidity-mortality, and all causes of death, better than commonly known risk factors such as diabetes, hypertension, cholesterol, and tobacco use.
The iHeartWatch® facilitates the automatic measure of cardiovascular markers without any additional action required from the user while also enabling your Smartphone to track the measures in the form of a trend curve. The combined analysis is performed to detect cardiovascular events as well as the warning signs for heart attack and stroke.
Outpatient measurement of arterial stiffness in patients with type 2 diabetes and obesity
BACKGROUND: Pulse wave velocity (PWV) is a marker of arterial stiffness. The aim of the present study was to compare PWV in patients with type 2 diabetes mellitus (T2DM) or obesity and healthy subjects in an outpatient setting. METHODS: A cross-sectional study was conducted in patients with obesity without T2DM (n = 37), T2DM without obesity (n = 40),…
Evaluation of arterial stiffness by finger-toe pulse wave velocity: optimization of signal processing and clinical validation
Carotid-femoral pulse wave velocity (PWV) (cf-PWV) is the gold standard for measuring aortic stiffness. Finger-toe PWV (ft-PWV) is a simpler noninvasive method for measuring arterial stiffness. Although the validity of the method has been previously assessed, its accuracy can be improved. ft-PWV is determined on the basis of a patented height chart for the distance and the pulse transit time (PTT) between the finger and the toe pulpar arteries signals (ft-PTT).
The Predictive Value of Pulse Wave Velocity for Anastomotic Leakage After Colorectal Surgery.
Arterial perfusion defects are a risk factor for anastomotic leakage (AL) following colorectal surgery. Measuring arterial stiffness using pulse wave velocity (PWV) is known to reflect the performance of the arterial network. The objective of this study was to assess the predictive value of PWV for AL after colorectal surgery.
Axelife® SAS is a French company that, since its formation in 2010, has specialized in the field of health. It designs and develops medical devices, and its flagship product, the “pOpmètre®”, is a device that diagnoses arteriosclerosis and accelerated arterial aging.
